JPRN-UMIN000001225已完成2 期
Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer. - Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
The Japan-multinational Trial Organization0 个研究点目标入组 90 人开始时间: 2008年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with serious infections or suspected infections with fever. 2)Pregnant or lactating women 3)Active concomitant malignancy 4)Past history of allergic reactions to polysorbate 80 5)Patients with interstitial pneumonia or pulmonary fibrosis, as determined by chest x-ray 6)Patients with inadequately controlled complications such as hypertension, congestive heart failure, myocardial infarction, arrhythmia, bleeding and diabetes. 7)Clinically significant pleural/pericardial effusion which requires treatment 8)Symptomatic brain metastases 9)Grade 2 or greater peripheral neuropathy 10)Patients judged by the investigator as unfit to be enrolled in the study
研究者
相似试验
已完成
2 期
A randomized phase II trial of docetaxel plus carboplatin versus docetaxel in hormone refractory prostate cancer patients who have progressed after response to prior docetaxel chemotherapy: RECARDO STUDYNL-OMON35127Vrije Universiteit Medisch Centrum150
进行中（未招募）
不适用
A randomized phase II trial of docetaxel plus carboplatin versus docetaxel in hormone refractory prostate cancer patients who have progressed after response to prior docetaxel chemotherapy: RECARDO STUDY - RECARDOEUCTR2007-004335-39-NLVU Medical Center150
尚未招募
2 期
DAROTAXEL2024-516939-28-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)245
招募中
2 期
A randomized phase II trial of docetaxel or cabazitaxel with or without darolutamide in men with metastatic castration-resistant prostate cancer.Metastatic castration-resistant prostate cancer10038597metastatic prostate cancerNL-OMON53373Erasmus MC, Universitair Medisch Centrum Rotterdam245
进行中（未招募）
不适用
A randomized phase II study of docetaxel in combination with oxaliplatin with or without 5-FU or capecitabine in metastatic or locally recurrent gastric cancer previously untreated with chemotherapy for advanced disease. - DOCOX GASTRIC (Docetaxel-Oxaliplatin in Gastric Cancer)Metastatic or local recurrent gastric cancer previously untreated with chemotherapy for advance disease.MedDRA version: 8.1Classification code 10017758EUCTR2005-005464-92-HUSanofi-aventis groupe270